"Through my heart's work of writing, I share with you, my complex journey a top the mountain, sliding down, crawling up, & living through the realms of Autoimmune Arthritic Illnesses. Taming "The Wolf" Thru each Day, One Step at a Time … Together We Are Learning to Survive. Please follow along, to New Beginnings - looking Thru the Window Pane of Pain in life where we shall find our journey leading us to - New Perspectives
Clinical Trial for Parkinson's Disease sponsored by Cure Click
Recruit for Parkinson's Disease sponsored by Cure Click
Share this clinical trial with your community using the sharing tools provided below. Be sure to include your unique link each time you share so that we can track your progress and reward you for your efforts.
Today, researchers are evaluating an investigational drug that focuseson the earliest stages of Parkinson’s disease that may potentially offer a new option for recently diagnosed patients.
If you have been recently diagnosed with Parkinson’s disease, you may want to consider a newly opened study. It is evaluating the safety and potential efficacy of an investigational drug that targets alpha-synuclein (α-syn), a molecule associated with Parkinson’s disease. The investigational drug is being studied to see if it may potentially help to slow or reduce disease progression.
For people who:
-- Have been diagnosed with Parkinson's disease in the last 3 years
-- Are 40 to 80 years of age
-- Have not received levodopa in the last 12 weeks